시장보고서
상품코드
1855959

세계의 집단유전체학 시장 보고서(2025년)

Population Genomics Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

집단유전체학 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 72억 2,000만 달러에서 2025년에는 82억 5,000만 달러로 CAGR 14.2%로 확대합니다. 실적 기간의 성장은 유전체 연구에 대한 투자 증가, 유전체 서비스 프로바이더의 확대, 소비자에게 직접 제공하는 유전체 서비스의 성장, 유전체 구상에 대한 정부 자금 증가, 유전체 연구 인프라의 발전으로 인해 이루어졌습니다.

포퓰레이션 유전체학 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 138억 4,000만 달러로 성장할 것이며, CAGR은 13.8%를 보일 것입니다. 예측 기간 중 성장의 원동력은 유전성 질환의 유병률 증가, 암 발병률 증가, 희귀질환의 부담 증가, 맞춤형 의료에 대한 수요 증가, 임상 진단에 대한 유전체학 통합의 진전 등으로 분석됩니다. 예측 기간의 주요 동향으로는 차세대 시퀀서의 발전, 단일 세포 유전체학의 발전, 유전체 분석에 인공지능의 통합, 시퀀싱 플랫폼의 소형화, 생물정보학 툴의 개선 등을 들 수 있습니다.

포퓰레이션 유전체학은 전체 유전체을 분석하여 생물 개체군 전체의 유전적 차이와 유사성을 연구하는 분야입니다. 진화, 자연도태, 이동, 유전적 드리프트 등의 요인이 시간이 지남에 따라 개체군의 유전적 구성을 어떻게 형성하는지 탐구합니다.

Population Genomics의 주요 제품 서비스는 소모품, 장비, 서비스, 소프트웨어입니다. 소모품은 시약, 테스트 키트, 분석 플레이트, 피펫 팁, 카트리지 등 실험에 필수적인 1회용 실험 재료로 구성되어 있습니다. 인간, 동물, 식물, 미생물 등 다양한 시료 유형에 적용되며, 약물유전체학, 질병 연구, 조상과 진화, 맞춤의료 등의 분야에서 사용되고 있습니다. 학술 및 연구기관, 제약 및 생명공학 기업, 병원 및 클리닉 등 다양한 최종사용자에게 서비스를 제공합니다.

2025년 봄, 미국의 갑작스러운 관세 인상과 그에 따른 무역 마찰은 헬스케어 분야, 특히 중요한 의료기기, 진단 기기, 의약품 공급에 심각한 영향을 미치고 있습니다. 병원과 의료 서비스 프로바이더들은 수입 수술기구, 영상 진단 장비, 주사기, 카테터 등 소모품의 비용 상승에 직면해 있습니다. 이러한 비용 상승은 의료 예산을 압박하고 있으며, 일부 의료기관은 장비 업그레이드를 늦추거나 환자에게 비용을 전가하고 있습니다. 또한 원자재 및 부품에 대한 관세는 필수적인 의약품 및 의료기기의 생산을 방해하여 공급망 병목현상을 유발하고 있습니다. 이에 대해 업계는 조달 전략을 다양화하고, 가능한 한 현지 생산을 촉진하고, 생명을 구하는 의료 제품에 대한 관세 면제를 옹호하고 있습니다.

이 보고서는 포퓰레이션 유전체학 산업 세계 시장 규모, 지역별 시장 점유율, 포퓰레이션 유전체학 시장 점유율을 보유한 경쟁사, 상세한 포퓰레이션 유전체학 시장 부문, 시장 동향 및 비즈니스 기회, 포퓰레이션 유전체학 산업에서 성공하기 위해 필요한 Population Genomics 시장 통계를 제공하는 The Business Research Company의 새로운 보고서 시리즈 중 하나입니다. 이 포퓰레이션 유전체학 시장 조사 보고서는 업계의 현재와 미래 시나리오를 상세하게 분석하여 필요한 모든 것을 완벽하게 제공합니다.

맞춤형 의료에 대한 수요 증가는 포퓰레이션 유전체학 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료란 개인의 유전적 체질에 따라 맞춤형 치료를 하는 것을 말합니다. 이러한 수요는 유전체 기술의 발전으로 비용이 낮아지고 표적치료제가 더 많은 사람들이 이용할 수 있게 됨에 따라 확대되고 있습니다. 포퓰레이션 유전체학은 특정 집단내 유전적 변이를 식별하고 의료진이 치료와 약물을 개별화하여 효과와 안전성을 향상시킬 수 있도록 함으로써 맞춤형 의료에서 중요한 역할을 하고 있습니다. 예를 들어 2024년 2월, 맞춤형 의료연합(Personalized Medicine Coalition)은 FDA가 2023년 희귀질환 환자를 위한 16개의 새로운 개인맞춤형 치료제를 승인했다고 보고했습니다. 맞춤형 의료가 점점 더 탄력을 받으면서 포퓰레이션 유전체학에 대한 수요는 계속 증가하고 있습니다.

포퓰레이션 유전체학 시장의 기업은 유전체 연구의 효율성, 정확성, 처리량을 향상시키기 위해 초고처리 라이브러리 준비 키트와 같은 첨단 툴 개발에 주력하고 있습니다. 이 키트는 하나의 워크플로우로 시퀀싱을 위한 대량의 DNA 또는 RNA 샘플을 신속하게 준비하고 여러 샘플 간의 높은 일관성을 보장하도록 설계되었습니다. 예를 들어 2024년 10월 미국 생명공학 기업 Twist Bioscience Corporation은 포퓰레이션 유전체학용 초고처리량 라이브러리 준비 키트인 FlexPrep을 발표했습니다. 이 키트는 독자적인 NBL(Normalization by Ligation) 기술을 이용하여 기존의 효소적 단편화 방법을 개선한 것입니다. 이 기술을 통해 번거로운 시료 정량이 불필요하고, 시료의 조기 풀링 및 다중화가 가능하며, 다양한 양의 시료를 쉽게 처리할 수 있습니다. 그 결과, 워크플로우의 효율성이 향상되고 대규모 차세대 염기서열 분석(NGS) 프로젝트에서 샘플당 비용이 절감됩니다. 또한 FlexPrep에는 독자적인 Twist 효소가 내장되어 있으며, 저비용으로 높은 처리량을 처리할 수 있으며, 포플리케이션 유전체학에서 NGS의 도입을 촉진합니다.

2024년 8월, 일본의 전자 및 전기 시스템 제조업체인 히타치 하이테크(Hitachi High-Tech Co., Ltd.)는 포퓰레이션 유전체학 전문 미국 기업 Nabsys를 인수했습니다. 이번 인수는 진단, 예후, 치료 분야에서 연구 성과가 기대되는 나브시스의 OhmX 기술의 채택을 가속화하기 위한 것입니다. 이번 인수를 통해 히타치제작소의 분자진단 사업, 특히 암 및 희귀질환 연구 분야가 강화될 것으로 보입니다.

포퓰레이션 유전체학 시장은 전장유전체 시퀀싱, 집단구조분석, 진화분석, 변이주석 등의 서비스를 제공하는 사업체가 얻는 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 포퓰레이션 유전체학 시장에는 차세대 시퀀서, 마이크로어레이 스캐너, 이미징 시스템, SNP 분석 장비의 매출도 포함됩니다. 이 시장의 가치는 '팩토리 게이트(공장 출고 시)' 가치로, 상품의 생산자 또는 제작자가 다른 사업자(다운스트림 생산자, 도매업체, 도매업체, 유통업체, 소매업체 포함) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 집단유전체학 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 용도 산업의 분석
  • 세계의 집단유전체학 시장 : 성장률 분석
  • 세계의 집단유전체학 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 집단유전체학 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계의 집단유전체학 : TAM(Total Addressable Market)

제6장 시장 세분화

  • 세계의 집단유전체학 시장 : 제품 서비스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 소모품
  • 인스트루먼트
  • 서비스
  • 소프트웨어
  • 세계의 집단유전체학 시장 : 샘플 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 인간
  • 동물
  • 플랜트
  • 미생물
  • 세계의 집단유전체학 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 약물유전체학
  • 질환 조사
  • 조상과 진화
  • 맞춤형 의료
  • 기타 용도
  • 세계의 집단유전체학 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 학술연구기관
  • 제약·바이오테크놀러지 기업
  • 병원·클리닉
  • 기타 최종사용자
  • 세계의 집단유전체학 시장 : 서브 세분화 소모품, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 시약
  • 키트
  • 프로브 및 어세이 패널
  • 효소
  • 버퍼와 미디어
  • 샘플 채취 및 보존 재료
  • 세계의 집단유전체학 시장 : 서브 세분화 기기, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 시퀸서
  • PCR 및 qPCR 기기
  • 마이크로어레이 플랫폼
  • 샘플 조제 및 추출 기기
  • 이미징 시스템
  • 자동화 및 로봇 시스템
  • 세계의 집단유전체학 시장 : 서브 세분화 서비스, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 시퀀스 서비스
  • 지노타이핑 서비스
  • 바이오인포매틱스와 데이터 해석 서비스
  • 샘플 조제 서비스
  • 커스텀 어세이 개발
  • 세계의 집단유전체학 시장 : 서브 세분화 소프트웨어, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 데이터 해석 소프트웨어
  • 게놈 어셈블리 소프트웨어
  • 배리언트 콜링 및 어노테이션 소프트웨어
  • 클라우드 기반 유전체학 플랫폼
  • 실험실 정보 관리 시스템(LIMS)

제7장 지역별·국가별 분석

  • 세계의 집단유전체학 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 집단유전체학 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 집단유전체학 시장 : 경쟁 구도
  • 집단유전체학 시장 : 기업 개요
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

  • Illumina Inc.
  • Charles River Laboratories
  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • Myriad Genetics Inc.
  • Takara Bio Inc
  • BGI Genomics Co. Ltd.
  • Invitae Corporation
  • 23andMe Inc.
  • Color Genomics Inc.
  • Helix OpCo LLC
  • Personalis Inc.
  • Centogene N.V.
  • Genomics England Limited
  • Veritas Genetics Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 집단유전체학 시장 2029 : 새로운 기회를 제공하는 국가
  • 집단유전체학 시장 2029 : 새로운 기회를 제공하는 부문
  • 집단유전체학 시장 2029 : 성장 전략
    • 시장 동향에 기반한 전략
    • 경쟁사 전략

제36장 부록

KSA 25.11.12

Population genomics is the field that studies the genetic differences and similarities across entire populations of organisms by analyzing their complete genomes. It explores how factors such as evolution, natural selection, migration, and genetic drift shape the genetic composition of populations over time.

The primary product services of population genomics include consumables, instruments, services, and software. Consumables consist of single use laboratory materials such as reagents, test kits, assay plates, pipette tips, and cartridges that are essential for performing experiments. It is applied to various sample types, including human, animal, plant, and microbial, and is used in areas such as pharmacogenomics, disease research, ancestry and evolution, personalized medicine, and others. It serves multiple end users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The population genomics market research report is one of a series of new reports from The Business Research Company that provides population genomics market statistics, including population genomics industry global market size, regional shares, competitors with a population genomics market share, detailed population genomics market segments, market trends and opportunities, and any further data you may need to thrive in the population genomics industry. This population genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The population genomics market size has grown rapidly in recent years. It will grow from $7.22 billion in 2024 to $8.25 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth during the historic period was driven by increasing investment in genomic research, expansion of genomic service providers, growth of direct to consumer genomics services, rising government funding for genomics initiatives, and development of genomic research infrastructure.

The population genomics market size is expected to see rapid growth in the next few years. It will grow to $13.84 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth during the forecast period is fueled by the rising prevalence of genetic disorders, increasing incidence of cancer, growing burden of rare diseases, rising demand for personalized medicine, and greater integration of genomics into clinical diagnostics. The primary trends in the forecast period include advancements in next generation sequencing, progress in single cell genomics, integration of artificial intelligence in genomic analysis, miniaturization of sequencing platforms, and improvements in bioinformatics tools.

The increasing demand for personalized medicine is expected to drive the growth of the population genomics market. Personalized medicine involves customizing medical treatments based on an individual's genetic makeup. This demand is growing as advancements in genomic technologies lower their cost, making targeted therapies more accessible to a wider population. Population genomics plays a critical role in personalized medicine by identifying genetic variations within specific populations, enabling healthcare providers to personalize treatments and medications for improved effectiveness and safety. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, compared to just six in 2022. As personalized medicine gains momentum, the demand for population genomics continues to rise.

Companies in the population genomics market are focusing on developing advanced tools such as ultra-high throughput library preparation kits to enhance the efficiency, accuracy, and throughput of genomic research. These kits are designed to rapidly prepare large numbers of DNA or RNA samples for sequencing in a single workflow, ensuring high consistency across multiple samples. For example, in October 2024, Twist Bioscience Corporation, a US-based biotechnology company, introduced FlexPrep, an ultra-high throughput library preparation kit for population genomics. The kit uses a unique Normalization by Ligation (NBL) technology, which improves traditional enzymatic fragmentation methods. This technology removes the need for labor-intensive sample quantification and enables early pooling and multiplexing of samples, making it easier to handle samples of varying amounts. The result is enhanced workflow efficiency and reduced per-sample costs for large-scale next-generation sequencing (NGS) projects. FlexPrep also incorporates a proprietary Twist enzyme that supports high-throughput processing at lower costs, promoting the adoption of NGS in population genomics.

In August 2024, Hitachi High-Tech Corporation, a Japanese manufacturer of electronic and electrical systems, acquired Nabsys, a US-based company specializing in population genomics. The acquisition is aimed at accelerating the adoption of Nabsys' OhmX technology, which is expected to advance research in diagnostics, prognostics, and therapeutics. The move will strengthen Hitachi's molecular diagnostics business, particularly in the fields of cancer and rare disease research.

Major players in the population genomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Illumina Inc., Charles River Laboratories, Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Takara Bio Inc, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Color Genomics Inc., Helix OpCo LLC, Personalis Inc., Centogene N.V., Genomics England Limited, Veritas Genetics Inc., Genuity Science, Gene by Gene Ltd., Nebula Genomics Inc., Ancestry.com LLC.

North America was the largest region in the population genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in population genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the population genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The population genomics market consists of revenues earned by entities by providing services such as whole genome sequencing, population structure analysis, evolutionary analysis, and variant annotation. The market value includes the value of related goods sold by the service provider or included within the service offering. The population genomics market also includes sales of next-generation sequencers, microarray scanners, imaging systems, and SNP analysis instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Population Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on population genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for population genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The population genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Service: Consumables; Instruments; Services; Software
  • 2) By Sample Type: Human; Animal; Plant; Microbial
  • 3) By Application: Pharmacogenomics; Disease Research; Ancestry And Evolution; Personalized Medicine; Other Applications
  • 4) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End-Users
  • Subsegments:
  • 1) By Consumables: Reagents; Kits; Probes And Assay Panels; Enzymes; Buffers And Media; Sample Collection And Storage Materials
  • 2) By Instruments: Sequencers; PCR And qPCR Instruments; Microarray Platforms; Sample Preparation And Extraction Instruments; Imaging Systems; Automation And Robotics Systems
  • 3) By Services: Sequencing Services; Genotyping Services; Bioinformatics And Data Analysis Services; Sample Preparation Services; Custom Assay Development
  • 4) By Software: Data Analysis Software; Genome Assembly Software; Variant Calling And Annotation Software; Cloud-Based Genomics Platforms; Laboratory Information Management Systems (LIMS)
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Labcorp Holdings Inc.; Regeneron Pharmaceuticals Inc.; Eurofins Scientific SE; Illumina Inc.; Charles River Laboratories; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Myriad Genetics Inc.; Takara Bio Inc; BGI Genomics Co. Ltd.; Invitae Corporation; 23andMe Inc.; Color Genomics Inc.; Helix OpCo LLC; Personalis Inc.; Centogene N.V.; Genomics England Limited; Veritas Genetics Inc.; Genuity Science; Gene by Gene Ltd.; Nebula Genomics Inc.; Ancestry.com LLC.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Population Genomics Market Characteristics

3. Population Genomics Market Trends And Strategies

4. Population Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Population Genomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Population Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Population Genomics Market Growth Rate Analysis
  • 5.4. Global Population Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Population Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Population Genomics Total Addressable Market (TAM)

6. Population Genomics Market Segmentation

  • 6.1. Global Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Instruments
  • Services
  • Software
  • 6.2. Global Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human
  • Animal
  • Plant
  • Microbial
  • 6.3. Global Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacogenomics
  • Disease Research
  • Ancestry And Evolution
  • Personalized Medicine
  • Other Applications
  • 6.4. Global Population Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Clinics
  • Other End-Users
  • 6.5. Global Population Genomics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Kits
  • Probes And Assay Panels
  • Enzymes
  • Buffers And Media
  • Sample Collection And Storage Materials
  • 6.6. Global Population Genomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencers
  • PCR And qPCR Instruments
  • Microarray Platforms
  • Sample Preparation And Extraction Instruments
  • Imaging Systems
  • Automation And Robotics Systems
  • 6.7. Global Population Genomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Services
  • Genotyping Services
  • Bioinformatics And Data Analysis Services
  • Sample Preparation Services
  • Custom Assay Development
  • 6.8. Global Population Genomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Genome Assembly Software
  • Variant Calling And Annotation Software
  • Cloud-Based Genomics Platforms
  • Laboratory Information Management Systems (LIMS)

7. Population Genomics Market Regional And Country Analysis

  • 7.1. Global Population Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Population Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Population Genomics Market

  • 8.1. Asia-Pacific Population Genomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Population Genomics Market

  • 9.1. China Population Genomics Market Overview
  • 9.2. China Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Population Genomics Market

  • 10.1. India Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Population Genomics Market

  • 11.1. Japan Population Genomics Market Overview
  • 11.2. Japan Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Population Genomics Market

  • 12.1. Australia Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Population Genomics Market

  • 13.1. Indonesia Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Population Genomics Market

  • 14.1. South Korea Population Genomics Market Overview
  • 14.2. South Korea Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Population Genomics Market

  • 15.1. Western Europe Population Genomics Market Overview
  • 15.2. Western Europe Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Population Genomics Market

  • 16.1. UK Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Population Genomics Market

  • 17.1. Germany Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Population Genomics Market

  • 18.1. France Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Population Genomics Market

  • 19.1. Italy Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Population Genomics Market

  • 20.1. Spain Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Population Genomics Market

  • 21.1. Eastern Europe Population Genomics Market Overview
  • 21.2. Eastern Europe Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Population Genomics Market

  • 22.1. Russia Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Population Genomics Market

  • 23.1. North America Population Genomics Market Overview
  • 23.2. North America Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Population Genomics Market

  • 24.1. USA Population Genomics Market Overview
  • 24.2. USA Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Population Genomics Market

  • 25.1. Canada Population Genomics Market Overview
  • 25.2. Canada Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Population Genomics Market

  • 26.1. South America Population Genomics Market Overview
  • 26.2. South America Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Population Genomics Market

  • 27.1. Brazil Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Population Genomics Market

  • 28.1. Middle East Population Genomics Market Overview
  • 28.2. Middle East Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Population Genomics Market

  • 29.1. Africa Population Genomics Market Overview
  • 29.2. Africa Population Genomics Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Population Genomics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Population Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Population Genomics Market Competitive Landscape And Company Profiles

  • 30.1. Population Genomics Market Competitive Landscape
  • 30.2. Population Genomics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Population Genomics Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Charles River Laboratories
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. QIAGEN N.V.
  • 31.5. Myriad Genetics Inc.
  • 31.6. Takara Bio Inc
  • 31.7. BGI Genomics Co. Ltd.
  • 31.8. Invitae Corporation
  • 31.9. 23andMe Inc.
  • 31.10. Color Genomics Inc.
  • 31.11. Helix OpCo LLC
  • 31.12. Personalis Inc.
  • 31.13. Centogene N.V.
  • 31.14. Genomics England Limited
  • 31.15. Veritas Genetics Inc.

32. Global Population Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Population Genomics Market

34. Recent Developments In The Population Genomics Market

35. Population Genomics Market High Potential Countries, Segments and Strategies

  • 35.1 Population Genomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Population Genomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Population Genomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제